GLP-1 receptor agonists effective for weight loss in obesity without diabetes

FHS
May 29, 2024
8:59 am

The benefit-harm balance of initiating Glucagon-like Peptide-1 (GLP-1) receptor agonists (RAs) versus a placebo intervention.

Three-Dose Lyme Vaccine Candidate Stimulates Immunogenicity, Appears Safe

An investigational three-dose Lyme vaccine (VLA15) against Borrelia outer surface protein A (OspA)-specific serotypes generated immunogenicity and appeared safe, according to results of two linked

June 6, 2024

Study finds power-motivated users share more fake news on social media

People motivated by power and the desire to influence others are more likely to share fake news posts on social media, according to a new

December 20, 2024

Should race be used in clinical algorithms? How one doctor’s research is helping shape policy

When the murder of George Floyd in 2020 ignited calls for racial equity across the U.S., the field of medicine confronted its own thorny questions

October 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.